Replies to post #4591 on BioCryst Pharmaceuticals,Inc. (BCRX)

[Deano361]

Link? Can't locate it

[0210]

From $7 to $11 and now @$16.00 vs. $6.10 currently(?). Only $900m mkt cap vs. "very deep BCRX product/mgt benches" and $2,000m up to $10,000m potential BO.

BCRX SOURCES:
December, 2020 >>> JPM Analyst Target PPS: $16.00 per share vs. $6.10 now.

September, 2020 >>> JPM Analyst Target PPS, $7.00 per share vs. $4.00 pps, then.